Bandhan BSE Healthcare Index Fund
The scheme seeks to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors.
Growthvine rating: 1/5 — ranked #227 of 245 in category.
Fund basics
| Category | Equity: Index |
|---|
| NAV | ₹11.52 (as of 2026-10-01) |
|---|
| AUM | ₹21 Cr |
|---|
| Expense ratio | 0.88% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Abhishek Jain |
|---|
| Exit load | 0.25% for redemption within 15 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −16.28% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Market cap allocation
| Large cap | 35.0% |
|---|
| Mid cap | 38.8% |
|---|
| Small cap | 26.2% |
|---|
Concentration
| Top 5 holdings | 35.2% |
|---|
| Top 10 holdings | 54.6% |
|---|
| Total holdings | 125 |
|---|
Top holdings
- Sun Pharmaceutical Industries Ltd. — 12.9%
- Divis Laboratories Ltd. — 7.2%
- Apollo Hospitals Enterprises Ltd. — 5.6%
- Cipla Ltd. — 4.9%
- Max Healthcare Institute Limited — 4.6%
- Laurus Labs Limited — 4.5%
- Torrent Pharmaceuticals Ltd. — 4.4%
- Dr. Reddys Laboratories Ltd. — 4.3%
- Lupin Ltd — 3.2%
- Fortis Healthcare Ltd — 2.9%
Top sectors
- Pharma & Biotech — 77.1%
- Healthcare — 23.0%
- Cash — −0.1%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 15.4% | — | — |
| 2025 | −3.8% | — | — |